278 related articles for article (PubMed ID: 24304412)
1. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
Beck T; Haasen C; Verthein U; Walcher S; Schuler C; Backmund M; Ruckes C; Reimer J
Addiction; 2014 Apr; 109(4):617-26. PubMed ID: 24304412
[TBL] [Abstract][Full Text] [Related]
2. Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial.
Socias ME; Wood E; Dong H; Brar R; Bach P; Murphy SM; Fairbairn N
Contemp Clin Trials; 2020 Apr; 91():105993. PubMed ID: 32194251
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.
Hämmig R; Köhler W; Bonorden-Kleij K; Weber B; Lebentrau K; Berthel T; Babic-Hohnjec L; Vollmert C; Höpner D; Gholami N; Verthein U; Haasen C; Reimer J; Ruckes C
J Subst Abuse Treat; 2014 Oct; 47(4):275-81. PubMed ID: 25064422
[TBL] [Abstract][Full Text] [Related]
4. Slow-release oral morphine as maintenance therapy for opioid dependence.
Ferri M; Minozzi S; Bo A; Amato L
Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540
[TBL] [Abstract][Full Text] [Related]
5. Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine.
Lehmann K; Kuhn S; Baschirotto C; Jacobsen B; Walcher S; Görne H; Backmund M; Scherbaum N; Reimer J; Verthein U
J Subst Abuse Treat; 2021 Aug; 127():108350. PubMed ID: 34134867
[TBL] [Abstract][Full Text] [Related]
6. Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care.
Baschirotto C; Lehmann K; Kuhn S; Reimer J; Verthein U
J Pharmacol Sci; 2020 Sep; 144(1):9-15. PubMed ID: 32586692
[TBL] [Abstract][Full Text] [Related]
7. Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study.
Verthein U; Beck T; Haasen C; Reimer J
Eur Addict Res; 2015; 21(2):97-104. PubMed ID: 25427944
[TBL] [Abstract][Full Text] [Related]
8. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
Bond AJ; Reed KD; Beavan P; Strang J
Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence.
Mitchell TB; White JM; Somogyi AA; Bochner F
Drug Alcohol Depend; 2003 Oct; 72(1):85-94. PubMed ID: 14563546
[TBL] [Abstract][Full Text] [Related]
10. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence.
Mitchell TB; White JM; Somogyi AA; Bochner F
Addiction; 2004 Aug; 99(8):940-5. PubMed ID: 15265090
[TBL] [Abstract][Full Text] [Related]
11. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
Falcato L; Beck T; Reimer J; Verthein U
J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification.
Madlung-Kratzer E; Spitzer B; Brosch R; Dunkel D; Haring C
Addiction; 2009 Sep; 104(9):1549-57. PubMed ID: 19686525
[TBL] [Abstract][Full Text] [Related]
13. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
Kastelic A; Dubajic G; Strbad E
Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and quality of life of opioid-dependent pregnant women in Austria.
Metz VE; Comer SD; Wuerzl J; Pribasnig A; Fischer G
Arch Womens Ment Health; 2014 Dec; 17(6):529-39. PubMed ID: 25023716
[TBL] [Abstract][Full Text] [Related]
15. Slow release oral morphine versus methadone for the treatment of opioid use disorder.
Klimas J; Gorfinkel L; Giacomuzzi SM; Ruckes C; Socías ME; Fairbairn N; Wood E
BMJ Open; 2019 Apr; 9(4):e025799. PubMed ID: 30944135
[TBL] [Abstract][Full Text] [Related]
16. One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years.
Nordt C; Vogel M; Dey M; Moldovanyi A; Beck T; Berthel T; Walter M; Seifritz E; Dürsteler KM; Herdener M
Addiction; 2019 Jan; 114(1):103-111. PubMed ID: 30209840
[TBL] [Abstract][Full Text] [Related]
17. Opioid agonist treatment for pharmaceutical opioid dependent people.
Nielsen S; Larance B; Degenhardt L; Gowing L; Kehler C; Lintzeris N
Cochrane Database Syst Rev; 2016 May; (5):CD011117. PubMed ID: 27157143
[TBL] [Abstract][Full Text] [Related]
18. Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis.
Ledlie S; Tadrous M; McCormack D; Campbell T; Leece P; Kleinman RA; Kolla G; Besharah J; Smoke A; Sproule B; Gomes T
Int J Drug Policy; 2023 Aug; 118():104119. PubMed ID: 37429161
[TBL] [Abstract][Full Text] [Related]
19. HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial.
Korthuis PT; King C; Cook RR; Khuyen TT; Kunkel LE; Bart G; Nguyen T; Thuy DT; Bielavitz S; Nguyen DB; Tam NTM; Giang LM
Lancet HIV; 2021 Feb; 8(2):e67-e76. PubMed ID: 33539760
[TBL] [Abstract][Full Text] [Related]
20. Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.
Gastberger S; Baumgartner MR; Soyka M; Quednow BB; Hulka LM; Herdener M; Seifritz E; Mutschler J
Eur Addict Res; 2019; 25(4):207-212. PubMed ID: 31067528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]